Barely Significant
← all excerpts

SEOM SOGUG clinical guideline for treatment of kidney cancer (2022).

Clin Transl Oncol · 2023 · PMC10425490 · PMID 37556095

1
hedged sentence
closest p
boldest claim

The sentences

The pooled HR for PFS was 1.30 (95% CI 0.91–1.86, p = 0.15), indicating a trend toward superiority of sunitinib over everolimus, although the results failed to reach statistical significance [ 113 ].

also in 6,035 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.